FDA
-
-
-
-
-
-
-
Gemini Therapeutics Announces Presentation of Previously Released Data from Its Ongoing Phase 2a Study of GEM103 at Clinical Trials at the Summit
-
-
-
-
-
-
-
Gemini Therapeutics (GMTX) Appoints Samuel Barone, M.D., as Chief Medical Officer
-
-
-
322,093 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

